Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in J Immunol Retrieve available abstracts of 9 articles: HTML format

Single Articles

September 2025
1. KEREMITCI D, Tuna O, Houdjedj A, Kazan H, et al
   Transcriptional states of lung cancer microenvironment reveal macrophage subtype dynamics linked to disease progression.
   J Immunol. 2025 Sep 16:vkaf253. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2025
2. SNYDER M, Wang Z, Lara B, Fimbres J, et al
   The aryl hydrocarbon receptor controls IFN-gamma-induced immune checkpoints PD-L1 and IDO via the JAK/STAT pathway in lung adenocarcinoma.
   J Immunol. 2025;214:413-432.
   PubMed     Abstract available
   
   
   November 2024
3. MA B, Kamle S, Sadanaga T, Lee CM, et al
   Chitinase 3-like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPalpha- and CD24-Siglec10-Mediated Phagocytosis.
   J Immunol. 2024;213:1279-1291.
   PubMed     Abstract available
   
   
   October 2024
4. OZAKINCI H, Song X, Nazario GS, Lila T, et al
   Rapid Autopsy to Define Dendritic Cell Spatial Distribution and T Cell Association in Lung Adenocarcinoma.
   J Immunol. 2024;213:1033-1041.
   PubMed     Abstract available
   
   
   September 2024
5. DIAMANTOPOULOS N, Li J, Bouchard A, Joumier L, et al
   ICOS-expressing Regulatory T Cells Influence the Composition of Antitumor CTL Populations.
   J Immunol. 2024;213:753-762.
   PubMed     Abstract available
   
   
   July 2024
6. SHANAHAN SL, Kunder N, Inaku C, Hagan NB, et al
   Longitudinal Intravascular Antibody Labeling Identified Regulatory T Cell Recruitment as a Therapeutic Target in a Mouse Model of Lung Cancer.
   J Immunol. 2024 Jul 31:ji2400268. doi: 10.4049/jimmunol.2400268.
   PubMed     Abstract available
   
   
   May 2024
7. SAXENA R, Bushey RT, Campa MJ, Gottlin EB, et al
   Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating Antibody.
   J Immunol. 2024;212:1589-1601.
   PubMed     Abstract available
   
   
   January 2024
8. TOYOFUKU T, Ishikawa T, Nojima S, Kumanogoh A, et al
   Efficacy against Lung Cancer Is Augmented by Combining Aberrantly N-Glycosylated T Cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor.
   J Immunol. 2024 Jan 12:ji2300618. doi: 10.4049/jimmunol.2300618.
   PubMed     Abstract available
   
   
   October 2023
9. RAV E, Maegawa S, Gopalakrishnan V, Gordon N, et al
   Overview of CD70 as a Potential Therapeutic Target for Osteosarcoma.
   J Immunol. 2023;211:1067-1072.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.